SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018447
Filing Date
2018-08-01
Accepted
2018-08-01 16:12:24
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20180630.htm 10-Q 2494020
2 EX-10.1 adro-ex101_100.htm EX-10.1 28213
3 EX-31.1 adro-ex311_6.htm EX-31.1 17950
4 EX-31.2 adro-ex312_7.htm EX-31.2 17859
5 EX-32.1 adro-ex321_8.htm EX-32.1 8116
  Complete submission text file 0001564590-18-018447.txt   9056563

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adro-20180630.xml EX-101.INS 2222664
7 XBRL TAXONOMY EXTENSION SCHEMA adro-20180630.xsd EX-101.SCH 53145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20180630_cal.xml EX-101.CAL 56218
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20180630_def.xml EX-101.DEF 190628
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20180630_lab.xml EX-101.LAB 418203
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20180630_pre.xml EX-101.PRE 339029
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 18984887
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1